Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Norden, M. A.
Right arrow Articles by Rabb, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Norden, M. A.
Right arrow Articles by Rabb, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 2426-2428
© 2001 European Renal Association-European Dialysis and Transplant Association


Teaching Point

Two haemodialysis patients with unclear abdominal symptoms of similar origin

(Section Editor: K. Kühn)

Mark A. Norden and Hamid Rabb

Hennepin County Medical Center, University of Minnesota, Minneapolis, Minnesota, USA

Keywords: amyloidosis; atherosclerosis; end-stage renal disease; ischaemic colitis; lymphoma

Introduction

Ischaemic colitis (IC) is a dangerous condition usually caused by atherosclerosis and low blood flow states [1]. Haemodialysis (HD) patients are at increased risk of IC because they have accelerated rates of arterial vascular disease [2] and because hypotension is common during dialysis with large amounts of fluid removal. Thus, IC in the HD patient is usually attributed to atherosclerotic origin. However, there are many other conditions that can contribute to IC including arterial occlusion, thrombosis, factors that increase blood viscosity, constipation causing increased intraluminal pressure [3,4], digoxin which acts as a splanchnic vasoconstrictor, impaired baroreflex sensitivity in chronic renal failure, and, rarely, neoplasm [5,6] or amyloidosis [7–10].

We report two cases of IC in HD patients of non-atherosclerotic aetiology. The first case is a unique presentation of IC in a HD patient in . . . [Full Text of this Article]

Cases

Case 1
Case 2
Discussion

Teaching points

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?